Vaccine News and Research

Latest Vaccine News and Research

PEI adjuvant improves effect of vaccines against flu, HIV and herpes

Oxford University scientists have discovered a compound that greatly boosts the effect of vaccines against viruses like flu, HIV and herpes in mice.

26 Aug 2012

Dartmouth’s professor shares news of DAR-901 TB vaccine development

Tuberculosis (TB) is second only to HIV/AIDS as the greatest killer worldwide attributable to a single infectious agent, according to the World Health Organization (WHO). With 8.8 million cases in 2010 and 95 percent of TB deaths occurring in low- and middle-income countries, the disease continues to be a major public health problem in the developing world. In a July address to the International Union Against Tuberculosis and Lung Disease, Dartmouth's C. Fordham (Ford) von Reyn shared news of a promising vaccine in the works.

24 Aug 2012

The Wistar Institute, MSKCC partner to publish first annotated atlas of Epstein-Barr virus genome

Researchers from The Wistar Institute and Memorial Sloan-Kettering Cancer Center (MSKCC) have teamed to publish the first annotated atlas of the Epstein-Barr virus genome, creating the most comprehensive study of how the viral genome interacts with its human host during a latent infection. Epstein-Barr virus (EBV), which is thought to be responsible for one percent of all human cancers, establishes a latent infection in nearly 100 percent of infected adult humans.

24 Aug 2012

New book sparks debate over whether vaccines cause autism

The bitter debate over whether vaccines cause autism is masking real problems with the modern inoculation schedule and encouraging a growing number of parents to refuse recommended vaccines for their children, argues a Michigan State University scholar.

23 Aug 2012

National Institute of Allergy and Infectious Diseases announces HIV vaccine initiative awards

"Researchers at 14 institutions will explore new approaches to designing a vaccine against HIV with awards that are part of an anticipated four-year, $34.8 million initiative, the National Institute of Allergy and Infectious Diseases [NIAID] announced Tuesday," the Center for Global Health Policy's "Science Speaks" blog reports.

23 Aug 2012

Mosquitoes in the U.S. can be infected with Chikungunya virus from Asia

New research from SRI International finds that mosquitoes commonly found in the United States can be infected with a disease-causing virus from Asia. The research findings are from a recent study that modeled how mosquito-borne infections can become introduced.

23 Aug 2012

New results describe development of DC cancer vaccine with enhanced immunogenic potential

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators at Radboud University Nijmegen Medical Centre in the Netherlands announced today that they have published new pre-clinical results in the journal Cancer Immunology Immunotherapy describing the development of a dendritic cell (DC) cancer vaccine with enhanced immunogenic potential.

23 Aug 2012

Aeras, IDRI announce start of first ID93 + GLA-SE Phase I trial for tuberculosis

Aeras and the Infectious Disease Research Institute (IDRI) announce today the start of the first clinical trial of IDRI's novel tuberculosis vaccine candidate, ID93 + GLA-SE.

23 Aug 2012

One blog examines GAVI Alliance's efforts to accelerate introduction of hepatitis B vaccines in developing countries

"I am looking forward to participating in the 2012 World Cancer Leaders' Summit, to be held in Montreal, Canada on August 27," GAVI Alliance Deputy CEO Helen Evans writes in this post in the One Blog.

23 Aug 2012

Link between specific weather conditions and dengue fever outbreaks

Dengue fever, transmitted by the Aedes mosquito, affects hundreds of millions of people in around one hundred tropical countries and causes 25 000 deaths per year. In the absence of a vaccine, determining the factors that influence epidemics to predict them better is a real public health challenge. One scientific study, conducted in New Caledonia, demonstrates the essential role of the local climate in epidemic dynamics. IRD researchers and their New Caledonian colleagues analysed epidemiological and climatological data gathered in Noumea over forty years.

23 Aug 2012

New PrescribeWellness initiative aims to increase flu vaccination rates in the U.S.

PrescribeWellness today launched its "A Million More" Flu Shot Initiative with the goal of increasing the influenza vaccination rate by one million more Americans.

22 Aug 2012

International community must redouble efforts to ensure 'many' AIDS-free generations

A Lancet editorial discusses the agenda of the XIX International AIDS Conference (AIDS 2012) in Washington last month and asks how the success of the conference will be judged at the XX International AIDS Conference (AIDS 2014), to be held in Melbourne, Australia.

22 Aug 2012

NIAID announces 14 grants for basic research to identify new HIV vaccine approaches

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded 14 grants totaling $7.8 million in first-year funding for basic research to identify new approaches for designing a safe and effective HIV vaccine.

22 Aug 2012

New silicon chips help identify patients with lupus

Researchers at the Stanford University School of Medicine and Intel Corp. have collaborated to synthesize and study a grid-like array of short pieces of a disease-associated protein on silicon chips normally used in computer microprocessors.

21 Aug 2012

WHO calls for emergency stockpile of cholera vaccine

The World Health Organization (WHO) is calling for the establishment of a global stockpile of the cholera vaccine to respond to outbreaks like the one that has gripped Haiti since an earthquake hit the country in 2010, NPR's "Shots" reports.

21 Aug 2012

BioDiem and French partner VIVALIS a step forward in developing vaccines for diseases and related cancers

Australian infectious disease therapy and vaccine development company BioDiem Ltd (ASX: BDM) announced today successful results from two programs of work carried out by French partner VIVALIS (NYSE Euronext: VLS), confirming the ability of BioDiem’s Live Attenuated Influenza Virus (LAIV) to grow in VIVALIS’ proprietary EB66® cell line.

20 Aug 2012

Ohio's three Clinical and Translational Science Award institutions establish IRB agreement

The three Clinical and Translational Science Award (CTSA) institutions in Ohio — Case Western Reserve University, University of Cincinnati and The Ohio State University — and their partnering institutions have established a statewide collaborative agreement allowing a single organization's Institutional Review Board (IRB) to assume IRB responsibilities on behalf of multiple institutions when conducting multicenter studies.

18 Aug 2012

New book on malaria tells story of Plasmodium falciparum Genome Project

Few infectious diseases can rival malaria's ability to kill and cripple. Each year the disease causes hundreds of millions of people to be sickened and more than a million - mostly African children under the age of five - die.

18 Aug 2012

FibeBiotics aims to prove benefits of polysaccharides in clinical trials

Staying healthy requires constantly stimulating the immune system. Ingesting non-digestible fibres such as polysaccharides is thought to help. Yet companies including such ingredients in their food products cannot claim that they boost the immune system. At least, not until they have been scientifically tested and proven in clinical trials. Only then, would the European Food Safety Agency (EFSA) allow such health claims.

18 Aug 2012

Viewpoints: Calif. health exchange off to good start; Fay Vincent on access problems for disabled; How 'upcoding' increases health costs

The California Health Benefits Exchange, established under the Patient Protection and Affordable Care Act to offer subsidized private coverage to most of the uninsured, represents an excellent opportunity to improve the quality and cost of healthcare in this state.

18 Aug 2012

Vaccine News and Research

Latest Vaccine News and Research

PEI adjuvant improves effect of vaccines against flu, HIV and herpes

Dartmouth’s professor shares news of DAR-901 TB vaccine development

The Wistar Institute, MSKCC partner to publish first annotated atlas of Epstein-Barr virus genome

New book sparks debate over whether vaccines cause autism

National Institute of Allergy and Infectious Diseases announces HIV vaccine initiative awards

Mosquitoes in the U.S. can be infected with Chikungunya virus from Asia

New results describe development of DC cancer vaccine with enhanced immunogenic potential

Aeras, IDRI announce start of first ID93 + GLA-SE Phase I trial for tuberculosis

One blog examines GAVI Alliance's efforts to accelerate introduction of hepatitis B vaccines in developing countries

Link between specific weather conditions and dengue fever outbreaks

New PrescribeWellness initiative aims to increase flu vaccination rates in the U.S.

International community must redouble efforts to ensure 'many' AIDS-free generations

NIAID announces 14 grants for basic research to identify new HIV vaccine approaches

New silicon chips help identify patients with lupus

WHO calls for emergency stockpile of cholera vaccine

BioDiem and French partner VIVALIS a step forward in developing vaccines for diseases and related cancers

Ohio's three Clinical and Translational Science Award institutions establish IRB agreement

New book on malaria tells story of Plasmodium falciparum Genome Project

FibeBiotics aims to prove benefits of polysaccharides in clinical trials

Viewpoints: Calif. health exchange off to good start; Fay Vincent on access problems for disabled; How 'upcoding' increases health costs

Industry Focus eBook - Infectious Diseases (2nd Edition) eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Vaccine News and Research

Latest Vaccine News and Research

Industry Focus eBook - Infectious Diseases (2nd Edition) eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Newsletters you may be interested in